Aptus-backed Alzheon hopes to raise $40.3m in proceeds, less than half as much as it had targeted earlier this year before withdrawing plans in May.

Tencent-backed smart vehicle developer Nio has set its pricing range at $6.25 to $8.25 and stands to raise $1.32bn if it floats at the top of its range.

The size of the deal for portfolio company NxThera could reach $406m in size, with Mitsui exiting the medical device maker through the acquisition.

Meituan Dianping's forthcoming initial public offering, which is expected to be $4bn in size, will feature Tencent as a cornerstone investor.

The Lilly Ventures, GV and Bluebird Bio-backed cancer immunotherapy developer has raised at least $188m in the past three years.

Since the beginning of 2017, Global Corporate Venturing (GCV) Analytics has tracked and seen a number of companies backed by China-based internet company Tencent go public in Hong Kong and the US.

The Square-backed event ticketing management software provider has disclosed almost $360m in venture funding.

Alibaba spinoff Koubei has joined forced with the corporate's newly acquired Ele.me, with more than $3bn from Alibaba and SoftBank.